Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)

Original languageEnglish
Article numberPP31
JournalScandinavian Journal of Rheumatology
Volume45
Issue numbersup 128
Pages (from-to)27-28
Number of pages2
ISSN0300-9742
Publication statusPublished - 2016

Cite this